NEWS JUNE 2016 ON FONTUP

Jovenes con Síndrome de Down mejoran su aprendizaje

NEWS JUNE 2016 ON FONTUP

NEW DATA AND NEWS ON JUNE 2016 FONTUP

I am back again to share with you some new data on FontUp.

As you know, this is a commercial product containing the right amount of epigallocatechin gallate (EGCG), a compound of green tea that, together with cognitive stimulation, enhances the capabilities in Down syndrome. Thus, I refer you to a post on my website about some historical data prior FontUp. The link is:

http://www.doctorlozano.com/down-syndrome-some-historical-data-prior-to-fontup/

Firstly, I would like to remind you that I do not have any commercial relationship with the company that manufactures FontUp. On the contrary, I only feel gratitude towards it due to a couple of reasons: being myself the father of a young woman with Down syndrome, and as a scholar of this field and especially of her mental health.

To give an overall picture of the post or go to the data that interest them as I bring my style, a brief table of contents or index:

1. Publication in the journal "The Lancet Neurology."

The results of phase 2 clinical trials were published on June 7, 2016, in the prestigious journal "The Lancet Neurology"."De la Torre et al. Safety and efficacy of cognitive training plus epigallocatechin-3 gallate for cognitive improvement in young adults with Down syndrome (TESDAD): a double-blind, randomised controlled, phase 2 trial. Lancet Neurology. 2016, 15: 801-810"

http://dx.doi.org/10.1016/S1474-4422(16)30034-5

http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(16)30034-5/abstract

It shows evidence that epigallocatechin gallate (EGCG), a compound present in green tea, along with a protocol of cognitive stimulation, can improve some intellectual abilities in young adults with Down syndrome.

2. Beginning of a study on EGCG in children aged between 1 and 15 years.

The research could be widened, and there is the aim to conduct the same survey with kids in paediatric ages

To see whether the effects obtained in adults are repeated in children. It exists the premise that neurodevelopmental processes in children are more plastic, and that the Dyrk1A gene and an excess of its Dyrk1a protein start acting and have a very active role in the development of children's nervous system.

3. FontUp in America.

I am informed that there is a delay in the distribution of the product

. The company that manufactures it is not responsible for it as it seems there are some problems with the patent of the name and that production has been overtaken by the sales in Spain. However, it will arrive within a short period to your country.

4. FontUp in Chile.

Chile is the first country in America to be distributed. Moreover, the date is very early: on August 25! And Dr Rafael La Torre will be in a chat together with ALLERGIKA, the distributor company. Those interested can join the contact list:

Chile is the first country in America to be distributed. Moreover, the date is very early: on August 25!

And Dr Rafael La Torre will be in a chat together with ALLERGIKA, the distributor company. Those interested can join the contact list:

http://www.allergikachile.com/producto/fontup/

5. FontUp's online availability in Spain:

I leave you some links to FontUp's online purchase, with which you can save some money when buying it:

I leave you some links to FontUp's online purchase, with which you can save some money when buying it:

http://www.farmaciamartorell.com/otros-productos/fontup.html

http://www.mifarma.es/laboratoires-grand-fontaine-fontup-down-6-un?fee=12&fep=35139&gclid=CNjivqbIpM0CFRUTGwod_ZQFwg

http://www.lafarmaciademodesta.com/nutricion-y-fitoterapia/nutricosmeticos/font-up-14-sobres-sin-gluten-sin-lactosa.html

Currently, Farmacia Soler is the one offering better terms: € 17.50 and with free shipping from € 60.

http://www.farmaciasoler.com/laboratorio-grand-fontaine-fontup-sabor-chocolate-14-sobres-p-18329.html#

6. I would like to remind you that FontUp does not cure Down syndrome

Although it is not a cure, there is a treatment showing some efficacy in this syndrome for the first time and opening the door to new research to treat a syndrome, which was believed to be an orphan

. I remind you Dr Dierssen's words, head of the group of Cellular Neurobiology and Systems at the Centre for Genomic Regulation and lead author of the study. "It is the first time a treatment proves effective in cognitive improvement of people with this syndrome. However, it must be clear that our discovery is not a cure for Down syndrome, but it can be a tool to improve the quality of life of these people."

7. The Lancet Neurology article commented in Spanish.

For those of you with some difficulties in reading the original article

, I refer you to this link of the Fundación Down21, which does an excellent job as usual.

http://www.down21.org/noticias/2944-lancet-neurology-te-verde-y-estimulacion-cognitiva-para-la-mejora-de-las-capacidades-en-sindrome-de-down.html

Comments for this post are closed.
Llanto en la depresión
Depression or depressions?

Quick NavigationTHERE IS NO UNIQUE DEPRESSION.COMMON FEATURES of DEPRESSIVE DISORDERSTYPES OF DEPRESSIVE DISORDERSEven types …

Obsessive-compulsive disorders OCD
Obsessive-compulsive disorders (OCD – TOC)

For me, speaking about the obsessive disorder is to speak about an old enemy I must defeatI have faced it every day for over …

Jovenes con Síndrome de Down mejoran su aprendizaje
NEWS JUNE 2016 ON FONTUP

NEW DATA AND NEWS ON JUNE 2016 FONTUP I am back again to share with you some new data on FontUp. As you know, this is a commercial …